GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Quest Diagnostics Inc (BSP:Q1UE34) » Definitions » 3-Year EPS without NRI Growth Rate

Quest Diagnostics (BSP:Q1UE34) 3-Year EPS without NRI Growth Rate : -6.00% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Quest Diagnostics 3-Year EPS without NRI Growth Rate?

Quest Diagnostics's EPS without NRI for the three months ended in Mar. 2024 was R$4.28.

During the past 12 months, Quest Diagnostics's average EPS without NRI Growth Rate was 3.00% per year. During the past 3 years, the average EPS without NRI Growth Rate was -6.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 11.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 13.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Quest Diagnostics was 92.10% per year. The lowest was -6.00% per year. And the median was 12.50% per year.


Competitive Comparison of Quest Diagnostics's 3-Year EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, Quest Diagnostics's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest Diagnostics's 3-Year EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Quest Diagnostics's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Quest Diagnostics's 3-Year EPS without NRI Growth Rate falls into.



Quest Diagnostics 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Quest Diagnostics  (BSP:Q1UE34) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Quest Diagnostics 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Quest Diagnostics's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest Diagnostics (BSP:Q1UE34) Business Description

Traded in Other Exchanges
Address
500 Plaza Drive, Secaucus, NJ, USA, 07094
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Quest Diagnostics (BSP:Q1UE34) Headlines

No Headlines